DAY ONE BIOPHARMACEUTICALS I (DAWN) Stock Cash Flow
USA - NASDAQ:DAWN - US23954D1090 - Common Stock
7.47 USD
-0.31 (-3.98%)
7.47 USD
0 (0%)
| TTM (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -95.00M | -95.50M | -188.92M | -142.18M | -72.75M | |||
| Depreciation Amortization | 3.36M | 2.03M | 383.00K | 60.00K | 20.00K | |||
| Change In Working Capital | -60.24M | 26.48M | 9.42M | 6.56M | 2.70M | |||
| Taxes Paid | N/A | 1.90M | N/A | N/A | N/A | |||
| Other non cash items | 88.82M | -11.13M | 32.26M | 25.68M | 21.50M | |||
| OPERATING CASH FLOW | -63.06M | -78.11M | -146.85M | -109.87M | -48.54M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -5.96M | -19.27M | -224.00K | -30.00K | 0.00 | |||
| Other Investing Activity | -337.67M | -211.72M | 128.60M | -255.05M | -8.00M | |||
| INVESTING CASH FLOW | -343.63M | -230.99M | 128.38M | -255.07M | -8.00M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Stock Issued/Repurchased | 24.52M | 25.11M | 164.00M | 165.90M | 297.12M | |||
| Other Financing Activity | N/A | 178.18M | N/A | N/A | 0.00 | |||
| FINANCING CASH FLOW | 202.69M | 203.29M | 164.00M | 165.90M | 297.12M | |||
| CHANGE IN CASH | -203.99M | -105.82M | 145.52M | -199.04M | 240.58M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -63.06M | -78.11M | -146.85M | -109.87M | -48.54M | |||
| Capital Expenditure | -5.96M | -19.27M | -224.00K | -30.00K | 0.00 | |||
| FREE CASH FLOW | -69.02M | -97.38M | -147.08M | -109.90M | -48.54M | |||
All data in USD